RxE2 Inc. — Form D/A
RxE2 Inc. of FARGO, ND, a company, filed a Form D amendment with the SEC on 2021-04-19. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Other.
Offering
- Filed: 2021-04-19
- Form: D/A
- Accession: 0001855833-21-000005
- Industry: Other
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $2.0M
- Date of first sale: 2021-03-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-396320
Issuer
- Name: RxE2 Inc.
- CIK: 0001855833
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 4302 13TH AVE S, STE. 4326, FARGO, ND, 58103
- Phone: 701-361-7650
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Gerald E Finken | Director | Fago, ND |
| Gerald E Finken | Executive Officer | Fago, ND |
| Gerald Finken | Director | Fargo, ND |
| Gerald Finken | Executive Officer | Fargo, ND |
Other filings by this issuer (3)
More